BERLIN and HAMBURG, Germany – Greenrise Global Brands Inc.’s (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX), announced the launch of its Herbify wellness brand of quality, cruelty-free and vegan CBD products designed to build on the power of the individual’s daily self-care routine.
Herbify CDB oils are designed to be used orally on a daily basis and contain organic hemp seed oil and CBD extract, essential fatty acids, vitamins, and minerals, as well as herbs, to form an important component of an individual’s self-care routine for physical and mental wellbeing.
The Herbify CBD line includes:
- Herbify Boost Me contains organic turmeric, black pepper, peppermint, and ginger oil and is designed to detoxify and help the immune system and focus. Available in 10 ml bottles for €34.90.
- Herbify Hold Me contains organic valerian, lavender which can help with relaxation. Available in 10 ml bottles for €34.90.
- Herbify Empower Me contains organic licorice root, cinnamon and is designed to influence intestine and blood circulation. Available in 10 ml bottles for €34.90.
- Herbify Pure 5% (€29.90) and Herbify Pure 10% (€54.90) contain pure organic hemp seed oil and CBD extracts. Available in 10 ml bottles.
Herbify’s CBD oils are made in Germany. All CBD products contain organically grown hemp CBD extract and are 100% natural, GMO-free and vegan. All Herbify products are laboratory-tested to ensure the highest quality and purity.
Mr. Hendrik Knopp, Director of Greenrise Global, “We paid close attention to how Germans are thinking about and consuming CBD. Our Herbify wellness brand is suited for the CBD enthusiast or someone experiencing CBD for the first time. Greenrise Global will be launching additional products to the German market which is anticipated to reach €1.6 billion by 20251”
Mr. Alex Hintz, Chief Product Officer of Greenrise Global, “The launch of the Herbify brand is just the first step on our exciting journey. We design products to help people to go about their day at greater ease and re-activate their natural potential. In the months ahead, we will be extending our product portfolio and are working on the next evolution in our product formulation to optimize bioavailability and efficacy.”
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accept responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking statements that are based on the Company’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans and milestones and the timing thereof. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements do not guarantee future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
(This information is primarily sourced from Greenrise Global Brands Inc. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).